Worth Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Worth Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,309	Closed	-$583K	–	140
2024 Q4	$583K	Sell	10,309 -30,202	-75%	-$1.69M	0.31%	66
2024 Q3	$2.1M	Buy	+40,511	New	+$1.9M	1.14%	20
2023 Q3	–	Sell	-429	Closed	-$27.4K	–	127
2023 Q2	$27.4K	Hold	429	–	–	0.02%	218
2023 Q1	$29.7K	Hold	429	–	–	0.02%	224
2022 Q4	$30.9K	Sell	429 -75	-15%	-$5.66K	0.02%	224
2022 Q3	$35K	Sell	504 -17,197	-97%	-$1.25M	0.03%	177
2022 Q2	$1.36M	Sell	17,701 -5,345	-23%	-$407K	0.93%	21
2022 Q1	$1.76M	Buy	+23,046	New	+$1.55M	1.15%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Worth Asset Management's BMY Position: Q1 2025 in Review

Worth Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 10,309 shares — an estimated $583K sold.

Worth Asset Management first reported a position in BMY in Q1 2022 and held it in 8 quarters. The position peaked at $2.1M in Q3 2024. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Worth Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Worth Asset Management sold 10,309 Bristol-Myers Squibb shares in Q1 2025, an estimated $583K.
Worth Asset Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 8 quarters.
Worth Asset Management's Bristol-Myers Squibb position peaked at $2.1M in Q3 2024.
2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Worth Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.